JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.95% |
| 2 | Technology | 12.9% |
| 3 | Financials | 12.36% |
| 4 | Healthcare | 9.31% |
| 5 | Consumer Discretionary | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
FTV.PRA
3251
DELISTED
Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A
FTV.PRA
| $1.96M | ﹤0.01% |
1,916
+1,871
| +4,158% | +$1.94M |
2018 Q4
2 quarters
|
|
3252
Plexus
PLXS
$7.27B
| $1.96M | ﹤0.01% |
33,935
+4,123
| +14% | +$238K |
2015 Q3
15 quarters
|
|
|
ALX
3253
Alexander's
ALX
$1.25B
| $1.96M | ﹤0.01% |
5,295
+2,581
| +95% | +$981K |
2015 Q3
15 quarters
|
|
3254
CALL
Royal Caribbean
RCL
$77.2B
| $1.96M | ﹤0.01% |
+16,400
| New | +$2M |
2019 Q2
0 quarters
|
|
3255
Innovative Industrial Properties
IIPR
$1.39B
| $1.95M | ﹤0.01% |
16,267
+13,070
| +409% | +$1.2M |
2017 Q3
7 quarters
|
|
|
FPRX
3256
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $1.95M | ﹤0.01% |
321,907
+78,404
| +32% | +$750K |
2015 Q4
14 quarters
|
|
3257
PUT
AstraZeneca
AZN
$246B
| $1.94M | ﹤0.01% |
+23,700
| New | +$1.86M |
2019 Q2
0 quarters
|
|
3258
Vanguard Morningstar Mega Cap Growth ETF
MGK
$35.5B
| $1.94M | ﹤0.01% |
75,260
+3,280
| +5% | +$83.5K |
2016 Q1
13 quarters
|
|
3259
Seres Therapeutics
MCRB
$29.1M
| $1.94M | ﹤0.01% |
33,614
+3,322
| +11% | +$315K |
2015 Q2
16 quarters
|
|
|
TARO
3260
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $1.93M | ﹤0.01% |
22,627
+11,197
| +98% | +$1.11M |
2015 Q4
14 quarters
|
|
3261
State Street SPDR MSCI USA Gender Diversity ETF
SHE
$336M
| $1.93M | ﹤0.01% |
26,312
| – | – |
2018 Q2
4 quarters
|
|
|
DOCU
3262
CALL
DocuSign
DOCU
$12.8B
| $1.93M | ﹤0.01% |
+38,000
| New | +$2.03M |
2019 Q2
0 quarters
|
|
3263
Lifetime Brands
LCUT
$211M
| $1.93M | ﹤0.01% |
209,007
-8,766
| -4% | -$80.1K |
2013 Q2
24 quarters
|
|
|
BNY
3264
PUT
Bank of New York Mellon
BNY
$97.5B
| $1.92M | ﹤0.01% |
44,300
+15,000
| +51% | +$705K |
2017 Q3
7 quarters
|
|
3265
Ormat Technologies
ORA
$5.72B
| $1.92M | ﹤0.01% |
30,664
+6,702
| +28% | +$399K |
2014 Q4
18 quarters
|
|
|
BMTC
3266
DELISTED
Bryn Mawr Bank Corp
BMTC
| $1.92M | ﹤0.01% |
51,814
+1,103
| +2% | +$41.3K |
2016 Q2
12 quarters
|
|
|
SRCL
3267
DELISTED
Stericycle Inc
SRCL
| $1.91M | ﹤0.01% |
40,062
+2,397
| +6% | +$122K |
2013 Q2
24 quarters
|
|
3268
Prothena Corp
PRTA
$412M
| $1.91M | ﹤0.01% |
189,645
+19,084
| +11% | +$196K |
2014 Q4
18 quarters
|
|
3269
Children's Place
PLCE
$42.5M
| $1.91M | ﹤0.01% |
20,365
-11,947
| -37% | -$1.22M |
2013 Q2
24 quarters
|
|
|
TLRD
3270
DELISTED
Tailored Brands, Inc.
TLRD
| $1.91M | ﹤0.01% |
331,736
+19,285
| +6% | +$134K |
2016 Q1
13 quarters
|
|
3271
CALL
Monster Beverage
MNST
$84.7B
| $1.91M | ﹤0.01% |
120,000
| – | – |
2019 Q1
1 quarter
|
|
|
3272
PUT
Monster Beverage
MNST
$84.7B
| $1.91M | ﹤0.01% |
120,000
| – | – |
2019 Q1
1 quarter
|
|
3273
Direxion Daily Gold Miners Index Bull 2X ETF
NUGT
$1.03B
| $1.91M | ﹤0.01% |
14,270
-482
| -3% | -$44.6K |
2018 Q3
3 quarters
|
|
3274
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.46B
| $1.91M | ﹤0.01% |
38,931
+4,597
| +13% | +$223K |
2013 Q2
24 quarters
|
|
|
IVC
3275
DELISTED
Invacare Corporation
IVC
| $1.9M | ﹤0.01% |
392,164
-83,096
| -17% | -$542K |
2016 Q1
13 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,668 increased, 2,116 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.